Director, Revenue and Inventory jobs in United States
cer-icon
Apply on Employer Site
company-logo

Praxis Precision Medicines, Inc. · 6 hours ago

Director, Revenue and Inventory

Praxis Precision Medicines is a biopharmaceutical company focused on developing transformative therapies for patients with central nervous system disorders. The Director, Revenue & Inventory will play a critical role in establishing the accounting and operational infrastructure necessary for commercialization, overseeing revenue and inventory accounting processes and ensuring compliance with related regulations.

Alternative MedicineBiotechnologyHealth CareMedicalPrecision Medicine
check
Comp. & Benefits

Responsibilities

Own the design and execution of revenue and inventory accounting processes, including revenue recognition, gross-to-net deductions, inventory valuation, reserves and GL close activities, in compliance with U.S. GAAP (ASC 606) and SOX requirements
Establish and maintain accounting processes related to government pricing programs, including Medicaid, Medicare and other federal and state programs, in partnership with market access and other key groups across the company, ensuring accurate accruals, reporting and compliance
Partner closely with cross functional stakeholders and external auditors to support accounting policy development, documentation, audit readiness and ongoing compliance as the company transitions to a commercial-stage organization
Design and operationalize gross-to-net processes, including controls, reconciliations and data flows with third-party vendors, market access and commercial operations to ensure accurate and timely accounting
Build and maintain inventory accounting and operational processes in partnership with supply chain and 3PL providers, including controls around inventory movements, obsolescence, write-offs and financial reporting
Lead the implementation and optimization of systems and tools supporting revenue, inventory and government pricing processes, including ERP and gross-to-net solutions, and define scalable processes and documentation to support future growth
Serve as the primary Finance partner for revenue, inventory and government pricing operations, providing clear guidance to cross-functional teams and contributing to the development of a strong compliant financial control environment

Qualification

CPAASC 606Revenue accountingInventory accountingGovernment pricing programsERP systemsSOX complianceIndependent operationCommunicationTeam collaboration

Required

Bachelor's degree in accounting, Finance or a related field; CPA strongly preferred
12–18+ years of progressive experience in revenue, inventory or technical accounting within biotech or pharmaceutical companies, including direct experience supporting early commercial launches
Deep knowledge of ASC 606, gross-to-net accounting, inventory accounting and government pricing-related accounting requirements
Experience supporting government pricing programs including Medicaid, Medicare and 340B
Experience supporting a pre- or early-commercial public biotech environment
Familiarity with ERP and gross-to-net systems and experience supporting SOX compliance and external audits
Ability to operate independently in a hands-on build-phase environment

Benefits

99% of the premium paid for medical, dental and vision plans.
Company-paid life insurance
AD&D
Disability benefits
Voluntary plans to personalize your coverage
We match dollar-for-dollar up to 6% on eligible 401(k) contributions
Long-term stock incentives
ESPP
Discretionary quarterly bonus
An extremely flexible wellness benefit
Generous PTO
Paid holidays
Company-wide shutdowns

Company

Praxis Precision Medicines, Inc.

twittertwittertwitter
company-logo
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance.

Funding

Current Stage
Public Company
Total Funding
$1.67B
Key Investors
Eventide
2026-01-06Post Ipo Equity· $575M
2025-10-16Post Ipo Equity· $525M
2024-03-28Post Ipo Equity· $200M

Leadership Team

leader-logo
Marcio Souza
President and CEO
linkedin
leader-logo
Tim Kelly
Chief Financial Officer
linkedin
Company data provided by crunchbase